Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Low income (World Bank)
Low income (World Bank): Diphtheria tetanus toxoid and pertussis third-dose (DTP3) was 74.0% in 2025. ▲ Rising
Latest (2025)
74.0%
Change on year
up 4.2%
Rank
11th
of 11 groups
All-time high
76.0%
in 2019
All-time low
47.0%
in 2000
Years of data
26
2000–2025
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Low income (World Bank), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Low income (World Bank) recorded 74.0% for diphtheria tetanus toxoid and pertussis third-dose (dtp3) in 2025.
The figure is up 4.2% on the previous year and up 2.8% over ten years.
Over the whole period, diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Low income (World Bank) peaked at 76.0% in 2019 and was at its lowest, 47.0%, in 2000.
The long-run direction has been consistently rising across the 26 years of available data.
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Low income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 47.0% | — |
| 2001 | 50.0% | +6.4% |
| 2002 | 52.0% | +4.0% |
| 2003 | 56.0% | +7.7% |
| 2004 | 60.0% | +7.1% |
| 2005 | 64.0% | +6.7% |
| 2006 | 66.0% | +3.1% |
| 2007 | 69.0% | +4.5% |
| 2008 | 70.0% | +1.4% |
| 2009 | 72.0% | +2.9% |
| 2010 | 72.0% | +0.0% |
| 2011 | 73.0% | +1.4% |
| 2012 | 72.0% | -1.4% |
| 2013 | 71.0% | -1.4% |
| 2014 | 73.0% | +2.8% |
| 2015 | 72.0% | -1.4% |
| 2016 | 73.0% | +1.4% |
| 2017 | 74.0% | +1.4% |
| 2018 | 75.0% | +1.4% |
| 2019 | 76.0% | +1.3% |
| 2020 | 73.0% | -3.9% |
| 2021 | 71.0% | -2.7% |
| 2022 | 72.0% | +1.4% |
| 2023 | 70.0% | -2.8% |
| 2024 | 71.0% | +1.4% |
| 2025 | 74.0% | +4.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 60.6% | 47.0% | 72.0% | 10 |
| 2010s | 73.1% | 71.0% | 76.0% | 10 |
| 2020s | 71.8% | 70.0% | 74.0% | 6 |
More health data for Low income (World Bank)
- Pertussis - number of reported cases, gaps filled 16,008 (2025)
- Total tetanus - number of reported cases, gaps filled 5,130 (2025)
- Diphtheria - number of reported cases, gaps filled 7,814 (2025)
- Measles - number of reported cases, gaps filled 197,977 (2025)
- Measles - number of reported cases, annual growth rate 6.99 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 289.49 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate -48.45 % change on previous year (2025)
- Diphtheria - number of reported cases 7,814 (2025)
- Total tetanus - number of reported cases 5,130 (2025)
- Pertussis - number of reported cases 16,008 (2025)
Frequently asked questions
- What is diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Low income (World Bank)?
- Diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Low income (World Bank) was 74.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Low income (World Bank)?
- The highest recorded value was 76.0% in 2019.
- What is the lowest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Low income (World Bank)?
- The lowest recorded value was 47.0% in 2000.
- How does Low income (World Bank) rank for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Low income (World Bank) ranks 11th out of 11 groups with data for 2025.
- Is diphtheria tetanus toxoid and pertussis third-dose (dtp3) rising or falling in Low income (World Bank)?
- Over the last ten years it is up 2.8%. The long-run trend across the full record is rising.
- Where does this Low income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).